BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16048459)

  • 1. Assessment of pharmacological toxicity using serum anticholinergic activity in a patient with dementia.
    Hori K; Funaba Y; Konishi K; Moriyasu M; Hirata K; Oyamada R; Tominaga I; Inada T
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):508-10. PubMed ID: 16048459
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.
    Gareri P; De Fazio P; Cotroneo A; Lacava R; Gallelli L; De Fazio S; De Sarro G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():199-206. PubMed ID: 17317453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic effects of medication in elderly patients.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():11-4. PubMed ID: 11584981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of behavioural and psychological symptoms of dementia in psychogeriatric inpatient units.
    Restifo S; Lemon V; Waters F
    Australas Psychiatry; 2011 Feb; 19(1):59-63. PubMed ID: 21189108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

  • 6. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic drugs in dementia: benefits and harm.
    Ballard C; Howard R
    Nat Rev Neurosci; 2006 Jun; 7(6):492-500. PubMed ID: 16715057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.
    Sittironnarit G; Ames D; Bush AI; Faux N; Flicker L; Foster J; Hilmer S; Lautenschlager NT; Maruff P; Masters CL; Martins RN; Rowe C; Szoeke C; Ellis KA;
    Dement Geriatr Cogn Disord; 2011; 31(3):173-8. PubMed ID: 21389718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances.
    Expert Consensus Panel for Dementia
    Postgrad Med; 2005 Jan; Spec No():1-111. PubMed ID: 17203560
    [No Abstract]   [Full Text] [Related]  

  • 11. Delusions in dementia: a review.
    Flint AJ
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):121-30. PubMed ID: 1687962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untangling the confusion. Alzheimer's management today.
    Wheldon M
    Adv Nurse Pract; 2005 May; 13(5):47-8, 50, 52. PubMed ID: 15898316
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
    Robinson M; Rowett D; Leverton A; Mabbott V
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiating behavioral disturbances of dementia from drug side effects.
    Eastham JH; Jeste DV
    Int Psychogeriatr; 1996; 8 Suppl 3():429-34; discussion 447-8. PubMed ID: 9154602
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of controlled pharmacologic trials.
    Schneider LS
    Int Psychogeriatr; 1996; 8 Suppl 3():375-9; discussion 381-2. PubMed ID: 9154592
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine for treatment-resistant agitation in dementia.
    Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG
    J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
    Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
    Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population.
    Sakakibara R; Uchiyama T; Yamanishi T; Kishi M
    Int J Urol; 2008 Sep; 15(9):778-88. PubMed ID: 18643858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.